4.2 Article

The anti- virulence activity of the non- mevalonate pathway inhibitor FR900098 towards Burkholderia cenocepacia is maintained during experimental evolution

期刊

MICROBIOLOGY-SGM
卷 168, 期 3, 页码 -

出版社

MICROBIOLOGY SOC
DOI: 10.1099/mic.0.001170

关键词

Burkholderia cenocepacia; biofilm; potentiator; anti-virulence; evolution; antibiotic resistance

资金

  1. Special Research Fund of Ghent University (Bijzonder Onderzoeksfonds, BOF) [BOF.DOC.2018.0023.01]

向作者/读者索取更多资源

This study evaluated the activity of FR900098 against B. cenocepacia, showing its ability to enhance the activity of colistin and various β-lactam antibiotics, slow down the development of resistance, and demonstrate anti-virulence effect in insect and nematode models.
Burkholderia cenocepacia infections are difficult to treat and there is an urgent need for alternative (combination) treatments. The use of anti- virulence therapies in combination with antibiotics is a possible strategy to increase the antimicrobial susceptibility of the pathogen and to slow down the development of resistance. In the present study we evaluated the ??-lactam and colistin- potentiating activity, and anti- virulence effect of the non- mevalonate pathway inhibitor FR900098 against B. cenocepacia in various in vitro and in vivo models. In addition, we evaluated whether repeated exposure to FR900098 alone or when combined with ceftazidime leads to increased resistance. FR900098 potentiated the activity of colistin and several ??-lactam antibiotics (aztreonam, cefepime, cefotaxime, ceftazidime, mecillinam and piperacillin) but not of imipenem and meropenem. When used alone or in combination with ceftazidime, FR900098 increased the survival of infected Galleria mellonella and Caenorhabditis elegans. Furthermore, combining ceftazidime with FR900098 resulted in a significant inhibition of the biofilm formation of B. cenocepacia. Repeated exposure to FR900098 in the C. elegans infection model did not lead to decreased activity, and the susceptibility of the evolved B. cenocepacia HI2424 lineages to ceftazidime, FR900098 and the combination of both remained unchanged. In conclusion, FR900098 reduces B. cenocepacia virulence and potentiates ceftazidime in an in vivo C. elegans model, and this activity is not lost during the experimental evolution experiment carried out in the present study.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据